Summer 2025
Posted on 2/21/2025
Global investment firm offering growth capital
$45.67 - $52.88/hr
New York, NY, USA
Internship is located in the New York office.
Internship is located in the New York office.
Internship is located in the New York office.
Find people who can refer or advise you
Sixth Street is a global investment firm that builds and executes investment themes to provide capital and strategic support across multiple growth stages. The firm makes equity and debt investments and also pursues co-investments, supporting companies in real estate, renewables, healthcare, and technology. Its products work by managing assets for clients and earning management fees while sharing in returns from investments, including capital appreciation, interest income, and dividends. Sixth Street differentiates itself through its broad sector coverage, emphasis on strategic guidance and cross-platform thinking, and its entrepreneurial approach, aiming to help clients grow and innovate. The firm’s goal is to generate durable value for its clients by deploying capital and advising on growth strategies that drive long-term performance.
Company Size
501-1,000
Company Stage
Post IPO Equity
Headquarters
San Francisco, California
Founded
2009
Find people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
Paid Holidays
Paid Sick Leave
Kpler Announces Strategic Growth Equity Investment from Sixth Street
Sixth Street to Become Majority Shareholder of Monument Re
The NFL announced today that it is partnering with TMRW Sports to develop and operate a professional flag football league for women and men. The new professional league will launch with support from a broad and influential investor pool, including NFL clu
Beam Therapeutics has secured a $500 million senior secured credit facility with Sixth Street to support the anticipated launch of ristoglogene autogetemcel (risto-cel) for sickle cell disease. The agreement includes $100 million funded at close, up to $300 million available upon clinical, regulatory and commercial milestones, and an additional $100 million at Beam's option. The facility has a seven-year term maturing in early 2033, with an annual interest rate of approximately 10% based on SOFR. No scheduled amortization payments are required, with all principal due at maturity. Beam expects to draw at least $200 million under the facility. The financing provides non-dilutive capital to support risto-cel's commercialisation whilst allowing Beam to direct resources towards pipeline growth and developing precision genetic medicines.
HPS Investment Partners and Sixth Street have provided approximately $700 million in private credit financing to Elara Caring, according to Bloomberg. The debt package supports a strategic investment from Ares Management's private equity arm and healthcare provider DaVita to fund expansion in the US home healthcare market. The transaction demonstrates private credit's expanding role in healthcare buy-and-build strategies, with direct lenders increasingly partnering with private equity sponsors on large-scale growth financings. Demand for home healthcare remains strong as ageing Baby Boomers reshape senior care, with a 2024 AARP survey showing most adults prefer to remain at home as they age. Representatives for Ares, HPS and Elara declined to comment.